Expression of mTOR/70S6K signaling pathway in pathological scar fibroblasts and the effects of resveratrol intervention

Mol Med Rep. 2017 May;15(5):2546-2550. doi: 10.3892/mmr.2017.6339. Epub 2017 Mar 16.

Abstract

The aim of the study was to examine the expression of mammalian target of rapamycin (mTOR)/70S6K signaling pathway in pathological scar fibroblasts and the effects of resveratrol (Res) intervention. The mTOR and 70S6K in pathological scar and normal skin fibroblasts were detected by immunofluorescence following treatment with different concentrations of Res. RT-PCR and western blot analysis were used to detect the expression of mTOR and 70S6K mRNA and protein, respectively. Immunofluorescence showed that the expression of 70S6K and mTOR was significantly enhanced in pathological scar fibroblasts, and mainly expressed in the nucleus, but not in normal skin fibroblasts. RT-PCR and western blot analysis showed that after different concentrations of Res treatments, the mTOR and 70S6K mRNA and protein expression significantly (P<0.05) decreased in a dose‑dependent manner. In conclusion, the expression of mTOR/70S6K signaling pathway in pathological scar fibroblasts was significantly enhanced. Res can downregulate the expression of mTOR and 70S6K to achieve the inhibition of pathological scar fibroblast proliferation.

MeSH terms

  • Cicatrix / drug therapy
  • Cicatrix / enzymology*
  • Female
  • Fibroblasts / enzymology*
  • Fibroblasts / pathology
  • Gene Expression Regulation, Enzymologic / drug effects*
  • Humans
  • Male
  • Resveratrol
  • Ribosomal Protein S6 Kinases, 70-kDa / biosynthesis*
  • Signal Transduction / drug effects*
  • Stilbenes / pharmacology*
  • TOR Serine-Threonine Kinases / biosynthesis*

Substances

  • Stilbenes
  • MTOR protein, human
  • Ribosomal Protein S6 Kinases, 70-kDa
  • TOR Serine-Threonine Kinases
  • Resveratrol